Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BHC source : Www.biospace.com save search
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
Published: 2024-03-06 (Crawled : 16:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.63%
H: 0.62%
C: -4.05%
cell pharmaceuticals study
Bausch Health Companies to Present at Cowen Annual Health Care Conference
Published: 2024-03-01 (Crawled : 14:30) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.85%
H: 4.54%
C: 4.44%
conference companies health care
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
Published: 2024-02-21 (Crawled : 19:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.0%
H: 2.5%
C: 0.81%
results
Salix Announces 2024 Gastrointestinal Health Scholars Program
Published: 2024-02-12 (Crawled : 13:30) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.24%
H: 3.28%
C: 1.82%
health program gastrointestinal
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
Published: 2024-02-01 (Crawled : 20:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.64%
H: 2.15%
C: 1.01%
health results
CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: -1.33%
treatment gel acne
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.0%
H: 4.27%
C: 2.56%
patent
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
Published: 2023-12-18 (Crawled : 14:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.0%
H: 2.06%
C: 1.24%
drug psoriasis treat
Bausch Health Announces Third-Quarter 2023 Results
Published: 2023-11-02 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 3.81%
H: 1.5%
C: -0.14%
health results
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
Published: 2023-11-01 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: -0.59%
H: 9.88%
C: 4.42%
results
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: -0.72%
H: 1.02%
C: -1.9%
health
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.81%
C: -1.35%
health results
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 1.18%
H: 1.81%
C: 0.52%
liver disease report health pharmaceuticals trends
Salix Pharmaceuticals Partners with Bellamy Young
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.25%
H: 0.37%
C: -0.12%
pharmaceuticals
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
Published: 2023-09-29 (Crawled : 22:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.0%
H: 1.15%
C: -0.24%
acquisition
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
Published: 2023-09-11 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -0.57%
acquisition
Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
Published: 2023-08-03 (Crawled : 12:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 4.82%
H: 3.73%
C: -3.78%
health
Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: -1.48%
H: 1.93%
C: 0.0%
results
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
Published: 2023-07-13 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 0.71%
H: 0.35%
C: -1.98%
health results
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
Published: 2023-07-11 (Crawled : 13:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M
|
Health Technology
|
| O: 1.26%
H: 1.02%
C: -2.15%
health program gastrointestinal
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.